Advantages of pyridostigmine bromide (mestinon) and edrophonium chloride (tensilon) in the treatment of transitory myasthenia gravis in the neonatal period (Q73855890)
Jump to navigation
Jump to search
scientific article published on 01 December 1955
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Advantages of pyridostigmine bromide (mestinon) and edrophonium chloride (tensilon) in the treatment of transitory myasthenia gravis in the neonatal period |
scientific article published on 01 December 1955 |
Statements
Advantages of pyridostigmine bromide (mestinon) and edrophonium chloride (tensilon) in the treatment of transitory myasthenia gravis in the neonatal period (English)